To evaluate the value of PTTG1 in predicting the prognosis of pancreatic cancer patients, we analyzed the association between its expression and overall survival (OS), disease-free survival (DFS), progression-free survival (PFS), and disease-specific survival (DSS) in the TCGA cohort. Here, PTTG1 is linked to pancreatic neoplasm.